|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Biofisica, Instituto Venezolano de Investigaciones Cientificas, Caracas, Venezuela; Anesthesiology Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, MA, USA
2 Biofisica, Instituto Venezolano de Investigaciones Cientificas, Caracas, Venezuela
3 Molecular Biosciences, University of California, Davis, CA, USA
4 Anesthesiology Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, MA, USA
* To whom correspondence should be addressed. E-mail: lopez{at}zeus.bwh.harvard.edu.
Malignant Hyperthermia (MH) is a potentially fatal pharmacogenetic syndrome caused by exposure to halogenated volatile anesthetics and/or depolarizing muscle relaxants. We have measured intracellular calcium concentration ([Ca2+]i), using doublebarreled Ca2+-selective microelectrodes in myoballs prepared from skeletal muscle from malignant hyperthermia susceptible (MHS) and non- susceptible (MHN) swine. Resting [Ca2+]i was aproximately 2 fold higher in MHS quiescent myoballs than in MHN quiescent myoballs (232±35 vs. 112±11 nM). Treatment of myoballs with caffeine or 4-chloro-m-cresol (4-CmC) produced an elevation of [Ca2+]i in both groups, however the concentration required to cause a rise in intracellular Ca2+ elevation was 4-fold lower in MHS than in MHN. Incubation of MHS cells with the fast complexing Ca2+ buffer BAPTA, reduced [Ca2+]i, raised the concentration of caffeine and 4-CmC required to cause an elevation of intracellular Ca2+ and reduced the amount of Ca2+ release associated with exposure to any given concentration of caffeine or 4-CmC to MHN levels. These results suggest that the differences in the response of MHS skeletal myoballs to caffeine and 4-CmC appears to be mediated, at least in part, by the chronic high resting calcium found in these cells.
This article has been cited by other articles:
![]() |
H. Zhou, N. Yamaguchi, L. Xu, Y. Wang, C. Sewry, H. Jungbluth, F. Zorzato, E. Bertini, F. Muntoni, G. Meissner, et al. Characterization of recessive RYR1 mutations in core myopathies Hum. Mol. Genet., September 15, 2006; 15(18): 2791 - 2803. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |